Sex-specific changes in the gut microbiome and associated metabolites came before disease progression in a mouse model of Rett…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
The European Commission has granted orphan drug designation to TSHA-102, an investigational gene therapy for the treatment of…
Using a comparative genomics approach, researchers have identified three potential therapies for Rett syndrome that are being used or…
Brain organoids grown from stem cells derived from people with Rett syndrome reproduced patterns of electrical brain activity that…
A first-generation university student has been awarded a six-year, $466,669 grant from the National Institutes of Health (NIH) to fund…
Treatment with a protein called CNF1 produced different results in two different mouse models of Rett syndrome, demonstrating a…
The use of microRNA molecules that targeted a protein receptor important for nerve cell growth led to improved behaviors and…
A study suggests lower intake of dietary protein is associated with more severe growth deficits in Taiwanese children…
People with Rett syndrome who grind their teeth during the day had a…
Due to the unprecedented challenges caused by the ongoing COVID-19 pandemic, GW Pharmaceutics has stopped the ARCH…